IRCT2012122311855N1已完成2 期
A randomized comparison between dabigatran and warfarin on coagulation activity and inflammatory markers in patients with atrial fibrillation
Tehran University of Medical Science0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •drug-refractory, symptomatic AF who had indications for ablation included in this study. Patients were excluded in the presence of a severe heart-valve disorder, stroke within 14 days or severe stroke within 6 months before screening, a condition that increased the risk of hemorrhage, a creatinine clearance of less than 30 ml per minute, an active liver disease, and pregnancy
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
ew medication for the prophylaxis of thrombosis in patients with mechanical heart supportpatients with implanted left ventricular assist deviceMedDRA version: 13.1Level: LLTClassification code 10052374Term: Left ventricular assist device insertionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-024534-38-ATMedizinische Universität Wien, Abteilung für Herzchirurgie30
招募中
3 期
efficacy and safety of dabigatran(paradxa) in pediatric thromboembolism Referring to Amir Kabir Hospital in Arakchildren-thromboemboli.Embolism and thrombosis of other arteriesIRCT20180711040431N1Arak University of Medical Sciences20
招募中
2 期
on-randomized confirmatory study of dabigatran bridge therapy in perioperative period of ESD for gastric neoplasms in patients on anticoagulantgastric cancerJPRN-UMIN000035353Cancer Institute Hospital150
Unknown
不适用
Real-World Effectiveness and Safety of Dabigatran in Geriatric Patients with Atrial FibrillatioDabigatran was used to prevent ischemic stroke in atrial fibrillation but effectiveness and safety are diferent between geriatric patients and young patients.dabigatran, non-vitamin k antagonist oral anticoagulants, NOAC, direct oral anticoagulant, DOAC, geriatric, elderly, atrial fibrillation, ischemic stroke, bleedingTCTR20221222001Faculty of Pharmacy, Silpakorn University2,134
已完成
4 期
A comparison of Dabigatran, Enoxaparin and Rivaroxaban for venous thromboembolism prophylaxisCondition 1: Deep vein thromboembolism. Condition 2: Malignant neoplasm of lower respiratory tract.Acute embolism and thrombosis of deep veins of lower extremityMalignant neoplasm of lower respiratory tract, part unspecifiedI82.4C39.9IRCT20200407046984N1Semnan University of Medical Sciences57